Literature DB >> 3539803

Formation of transmural complement pores in serum-sensitive Escherichia coli.

S Bhakdi, G Kuller, M Muhly, S Fromm, G Seibert, J Parrisius.   

Abstract

The binding of C9 at 0 and 37 degrees C to viable Escherichia coli K-12 cells carrying C5b-8 complexes was quantified. At low temperature, limited average binding of only 1 to 1.4 molecules of C9 per C8 molecule occurred, whereas 6 to 8 C9 molecules were bound per C8 molecule at 37 degrees C. Despite incorporation of C9 into C5b-9 complexes at 0 degrees C, these terminal complexes caused no loss of bacterial viability even when present in very large numbers (1,000 to 1,500 per CFU) on the bacterial cells. In contrast, generation of 50 to 100 C5b-9 complexes carrying multiple C9 molecules per CFU caused loss of viability. The failure of C5b-81C91 complexes to generate transmural pores was confirmed by measurements of o-nitrophenyl-beta-D-galactoside influx into the cells. Whereas treatment of C5b-8-laden cells with C9 at 32 degrees C caused virtually instantaneous influx of the marker, almost no influx was registered in cells receiving C9 at 0 degrees C. When cells carrying C5b-7 were brought into the stationary phase and given C8 and C9 at 32 degrees C, a C9-dependent disruption of the outer membrane permeability barrier immediately occurred as demonstrated by cleavage of a chromogenic substrate by periplasmic beta-lactamase. In sharp contrast, o-nitrophenyl-beta-D-galactoside influx was markedly retarded over a prolonged period, with abrupt permeability increases of the inner membrane toward this molecule being noted just before bacterial cell division occurred. We conclude that killing of E. coli requires binding of C5b-9 complexes containing C9 oligomers to the outer membrane and suggest that formation of pores in the inner membrane occurs when these complexes are "hit" by transiently forming zones of bioadhesion. Formation of the latter may be a dynamic process that is accentuated during cell division and quiescent during the stationary phase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3539803      PMCID: PMC260303          DOI: 10.1128/iai.55.1.206-210.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  The relationship between channel size and the number of C9 molecules in the C5b-9 complex.

Authors:  L E Ramm; M B Whitlow; M M Mayer
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

2.  Does complement kill E. coli by producing transmural pores?

Authors:  J Born; S Bhakdi
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

3.  C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

4.  The membrane attack complex of complement: C5b-8 complex as accelerator of C9 polymerization.

Authors:  J Tschopp; E R Podack; H J Müller-Eberhard
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

5.  [An enzymic method for the determination of cefotaxim in serum and urine (author's transl)].

Authors:  G Seibert; A Biebach
Journal:  J Clin Chem Clin Biochem       Date:  1981-05

6.  On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

7.  Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.

Authors:  J L Stewart; J B Monahan; A Brickner; J M Sodetz
Journal:  Biochemistry       Date:  1984-08-28       Impact factor: 3.162

8.  Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.

Authors:  K A Joiner; M A Schmetz; M E Sanders; T G Murray; C H Hammer; R Dourmashkin; M M Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

9.  Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.

Authors:  P J Sims
Journal:  Biochim Biophys Acta       Date:  1983-08-10

10.  Membrane changes induced by exposure of Escherichia coli to human serum.

Authors:  H P Kroll; S Bhakdi; P W Taylor
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

View more
  15 in total

1.  Growth phase influences complement resistance of Bordetella pertussis.

Authors:  Michael G Barnes; Alison A Weiss
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  Pore formation by complement in the outer membrane of gram-negative bacteria studied with asymmetric planar lipopolysaccharide/phospholipid bilayers.

Authors:  G Schröder; K Brandenburg; L Brade; U Seydel
Journal:  J Membr Biol       Date:  1990-11       Impact factor: 1.843

Review 3.  Functions and relevance of the terminal complement sequence.

Authors:  S Bhakdi; F Hugo; J Tranum-Jensen
Journal:  Blut       Date:  1990-06

4.  C9-mediated killing of bacterial cells by transferred C5b-8 complexes: transferred C5b-9 complexes are nonbactericidal.

Authors:  K P Blanchard; J R Dankert
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

5.  Affinity of the C9 molecule for the C5b-8 complex compared with that for the complex containing C9 molecules.

Authors:  S L MacKay; J R Dankert
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

6.  Sub-minimal inhibitory concentrations of cefmetazole enhance serum bactericidal activity in vitro by amplifying poly-C9 deposition.

Authors:  J E Schweinle; M Nishiyasu
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

7.  Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli.

Authors:  B A Mannion; J Weiss; P Elsbach
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

8.  Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.

Authors:  R I Lehrer; A Barton; K A Daher; S S Harwig; T Ganz; M E Selsted
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

9.  Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.

Authors:  J Weiss; P Elsbach; C Shu; J Castillo; L Grinna; A Horwitz; G Theofan
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  Mechanism of resistance to complement-mediated killing of bacteria encoded by the Salmonella typhimurium virulence plasmid gene rck.

Authors:  E J Heffernan; S Reed; J Hackett; J Fierer; C Roudier; D Guiney
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.